Guardant Health, Inc. · NASDAQ:GH
T. Rowe Price Associates Inc reported a 5.40% stake in Guardant Health, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed May 15, 2026
T. Rowe Price Associates Inc reported a 5.40% stake in Guardant Health, Inc., 7,035,771 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).
- Stake
- 5.40%
- Shares
- 7,035,771
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Associates, Inc. | 5.40% | 7,035,771 |
Source
Related
- Guardant Health, Inc.
- T. Rowe Price Associates Inc
- Guardant Health, Inc. shareholders
- Schedule 13G/A · T. Rowe Price Associates Inc · Aug 14, 2026
- Form 4 · Mignone Roberto · Oct 22, 2026
- Form 4 · Hidalgo Medina Manuel · Oct 19, 2026
- Form 4 · Tariq Musa · Oct 19, 2026
- Form 4 · Azar Alex M II · Oct 15, 2026
- Form 4 · Azar Alex M II · Oct 13, 2026